FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Expands Approval of Sanofis Tzield to Younger Children

FDA approves an expanded indication for Sanofis Tzield (teplizumab), allowing its use in children as young as one year old to delay the onset of stage...

Human Drugs

UCSF Radiopharmaceutical Facility CGMP Issues

FDA warns the University of California at San Francisco radiopharmaceutical facility about CGMP violations in its production of finished drugs.

latest-news-card-1
Human Drugs

CGMP Violations at Par Health USA/Endo USA

FDA warns Par USA/Endo USA about CGMP violations in its manufacturing of finished drugs.

latest-news-card-1
Human Drugs

Multiple Violations at Chinas Xiamen Kang

FDA warns Chinas Xiamen Kang Zhongyuan Biotechnology Co. about producing drugs in insanitary conditions and making misleading or deceptive statements ...

latest-news-card-1
Human Drugs

New FDA AEMS Dashboard Needs Context, Transparency: Professors

Two pharmacy professors say FDA needs to solicit expert and client input on its new Adverse Event Monitoring System dashboard and use the input to res...

latest-news-card-1
Biologics

FDA Accepts Roche sBLA for Gazyva in Lupus

FDA accepts a Roche supplemental BLA that seeks to expand use of Gazyva to treat Systemic Lupus Erythematosus.

latest-news-card-1
Human Drugs

Makary Support Vouchers for Psychedelic Therapies

FDA commissioner Marty Makary tells Fox Business that the agency will deploy its new national priority voucher program to significantly shorten drug r...

latest-news-card-1
FDA General

FDA Approves Mercks Idvynso for Treating HIV

FDA approves Mercks Idvynso, a once-daily, single-tablet regimen for adults with HIV-1 who are already virologically suppressed.

latest-news-card-1
FDA General

Outlook Therapeutics Completes FDA Dispute Meeting on Lytenava

Outlook Therapeutics completes a formal dispute resolution meeting with FDA as part of the companys push to revive its approval prospects for ONS-5010...

FDA General

FDA Lays Out Next Phase of Plan to Reduce Animal Testing

FDA outlines expanded efforts to reduce animal testing in drug development after reporting significant first-year progress under its roadmap to modern...